NCT07455851
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07455851
Title A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Prince of Wales Hospital RECRUITING Randwick New South Wales 2031 Australia Details
Illawarra Cancer care centre, Wollongong Hospital RECRUITING Wollongong New South Wales 2500 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field